International Stem Cell Corporation a California-based biotechnology company, today announced the conclusions from its study demonstrating the efficacy and safety of the hepatocyte-like cells derived from human parthenogenetic stem cells in a well-established animal model of a congenital liver disorder associated with bilirubin metabolism.
http://www.biospace.com/news_story.aspx?StoryID=287427&full=1
http://www.biospace.com/news_story.aspx?StoryID=287427&full=1
No comments:
Post a Comment